China Cord Blood Corporation. (CO) 7.22 $CO China Cord

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Cord Blood Corporation. (CO) 7.22 $CO

China Cord Blood Corporation (CO) Rises: Stock Up 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 8:32AM CDT
China Cord Blood Corporation (CO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
ADUS: 28.86 (+0.41), CO: 7.22 (+0.42)

How it All Plays Out: Complementary Research on China Cord Blood, Biolase, Cara Therapeutics, Tonix, and Enzo Biochem
PR Newswire - Fri Apr 24, 8:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CARA: 12.71 (-0.15), ENZ: 3.01 (-0.02), TNXP: 6.52 (-0.15), BIOL: 2.17 (+0.01), CO: 7.22 (+0.42)

China Cord Blood (CO) Is Today's Strong On High Volume Stock
at The Street - Wed Apr 22, 9:06AM CDT
Trade-Ideas LLC identified China Cord Blood (CO) as a strong on high relative volume candidate
CO: 7.22 (+0.42)

28.7% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 21, 11:34AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 3 months, China Cord Blood has returned 28.72% as of today's recent price of $6.32.
CO: 7.22 (+0.42)

American Eagle Outfitters and Make It Right Launch National Denim Recycling Program for Earth Day
Business Wire - Mon Apr 20, 9:38AM CDT
In honor of Earth Day, Make It Right is kicking off a partnership with leading apparel company American Eagle Outfitters to recycle used and unwanted denim into building materials for affordable homes.
AEO: 17.15 (+0.05), CO: 7.22 (+0.42)

China Cord Blood: Attractive Buyout Target With 22.4% Upside And Minimal Bloodletting
Jennifer Wang - at Seeking Alpha - Thu Apr 16, 1:53PM CDT

CO: 7.22 (+0.42)

17.1% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 14, 10:32AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 17.11% as of today's recent price of $5.75.
CO: 7.22 (+0.42)

Uptrend Call Working As China Cord Blood Stock Rises 23.0% (CO)
Comtex SmarTrend(R) - Tue Apr 07, 9:24AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.01% as of today's recent price of $6.04.
CO: 7.22 (+0.42)

Shares of CO Up 15.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 30, 10:08AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 15.48% as of today's recent price of $5.67.
CO: 7.22 (+0.42)

BUYINS.NET: ENS, EOC, AUO, CO, IDT, DPZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 27, 7:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EnseCo Energy Services Corp (NYSE:ENS), Empresa Nacional de Electricidad SA (NYSE:EOC), AU Optronics Corp (NYSE:AUO), China Cord Blood Corp (NYSE:CO), IDT Corp (NYSE:IDT), Domino's Pizza Inc (NYSEPZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AUO: 5.14 (+0.08), IDT: 17.70 (+0.10), DPZ: 113.96 (+4.73), CO: 7.22 (+0.42), EOC: 46.39 (+0.40), ENS: 68.27 (-0.41)

China Cord Blood (CO) Worth Watching: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 8:25AM CDT
China Cord Blood (CO) was a big mover last session, with shares rising over 7% on the day.
CHE: 123.62 (+0.08), CO: 7.22 (+0.42)

CEOs Just Can't Let Go of the Company Jet for Personal Use – Even When They Should
at The Street - Mon Mar 23, 10:59AM CDT
In times of trouble, one might think companies would be quick to squeeze the personal corporate jet perk for CEOs from their budgets. But many are holding on tight.
GE: 26.80 (-0.05), NKE: 100.95 (-0.16), UTX: 116.16 (-1.10), C: 52.90 (-0.32), CHTR: 185.75 (+2.17), WFC: 54.70 (-0.16), MHFI: 106.23 (+0.97), BA: 148.40 (-1.47), PEP: 95.17 (-0.56), CI: 130.66 (+0.09), GS: 197.99 (-1.32), IBM: 169.78 (-0.46), TGT: 82.70 (+0.77), CO: 7.22 (+0.42)

Shares of CO Up 23.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 23, 9:33AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.83% as of today's recent price of $6.08.
CO: 7.22 (+0.42)

An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
PR Newswire - Thu Mar 19, 11:24AM CDT
The following is an open letter sent March 19, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital.
CO: 7.22 (+0.42)

China Cord Blood's (CO) CEO Tina Zheng on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 12:28PM CST

CO: 7.22 (+0.42)

China Cord Blood Corp (CO) Jumps: Stock Up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 8:25AM CST
China Cord Blood Corp (CO) was a big mover last session, with shares rising over 9% on the day.
CO: 7.22 (+0.42), AMED: 26.82 (unch)

How it All Plays Out: Special Research on Global Defense & National Security Systems, HF2 Financial Management, American Apparel, JetPay, and CCBC
PR Newswire - Tue Feb 17, 8:20AM CST
Editor Note: For more information about this release, please scroll to bottom.
APP: 0.64 (-0.03), GDEF: 10.44 (+0.01), JTPY: 3.20 (-0.05), CO: 7.22 (+0.42), HTWO: 9.70 (-0.11)

China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2015 Financial Results
PR Newswire - Tue Feb 17, 6:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company" today announced its plan to release its unaudited financial results for the third quarter and first nine months of fiscal 2015 on Wednesday, February 25, 2015, after market close in the US.
CO: 7.22 (+0.42)

Keep An Eye On China Cord Blood
Jack Banser - at Seeking Alpha - Tue Feb 10, 8:19AM CST

CO: 7.22 (+0.42)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Xinjiang's International Week Sparks Global Agricultural Talks

Updated Category News Views 22

Shihezi's Global Stage: A Week of Shared Opportunities Shihezi, tucked away in the far reaches of Xinjiang, China, has become a hub of global discourse this week. Here's the kicker—an International Week filled with events aiming to connect the dots between technological innovation and agricultural advancement kicked off on August 31. Look, they've got experts and...

Continue Reading
Essity's Strategic Buyback Program for Class B Shares

Updated Category News Views 189

Essity Aktiebolag Initiates Class B Share Buyback Essity Aktiebolag (publ) has taken a significant step in its growth strategy by repurchasing a total of 270,000 Class B shares. This decision, made between February 10 and February 14, 2025, marks a critical component of the company’s ongoing commitment to enhance shareholder value. Overview of the Buyback Program The...

Continue Reading
Exploring Opendoor's Stock Surge: Key Insights Unveiled

Updated Category News Views 137

Opendoor Technologies Inc Stock Performance Opendoor Technologies Inc (NASDAQ: OPEN) has been witnessing notable movement in the stock market recently, prompting investor interest. The company, known for its innovative approach to real estate, is adapting to new market conditions and strategic initiatives that are influencing its share prices positively. Support for...

Continue Reading
Market Challenges Impact Project Energy's Stock Performance

Updated Category News Views 50

Market Challenges Impact Project Energy Reimagined Acquisition Corp. In a striking indicator of the turbulent market landscape, Project Energy Reimagined Acquisition Corp. (PITA) has seen its stock plunge to a 52-week low, with shares dropping to a challenging $0.95. This significant decline reflects a severe downturn for PITA, characterized by a staggering one-year...

Continue Reading
Emergency Actions Following South Korea's Largest Airline Crash

Updated Category News Views 436

South Korea's Urgent Response to Air Disaster In a significant response to the aviation crisis, acting President Choi Sang-mok has mandated an immediate overhaul of South Korea's airline safety protocols. This decision came after the nation faced its deadliest air disaster, resulting in a tragic loss of 179 lives when a flight encountered catastrophic failure in landing....

Continue Reading